Literature DB >> 20022823

Descriptive epidemiology of cholangiocarcinoma in Italy.

Domenico Alvaro1, Emanuele Crocetti, Stefano Ferretti, Maria Consiglia Bragazzi, Riccardo Capocaccia.   

Abstract

BACKGROUND: Very little data exist on the epidemiology of cholangiocarcinoma in Italy. AIM: We focus on the descriptive epidemiology of cholangiocarcinoma in Italy.
METHODS: Data on incidence were obtained from the Italian Association of Tumour Registries while mortality data were obtained from the Italian National Institute of Statistics.
RESULTS: A progressive increase of incidence with age was seen for extra-hepatic, intra-hepatic and not otherwise specified cholangiocarcinoma. Crude incidence rates were higher for extra-hepatic cholangiocarcinoma than those for intra-hepatic cholangiocarcinoma and in men compared to women. An increasing incidence trend was observed, from 1988 to 2005, for both extra-hepatic- and intra-hepatic cholangiocarcinoma with a 3-6% yearly increase and with a rate of increase higher for men than for women and for intra-hepatic- than for extra-hepatic cholangiocarcinoma. For intra-hepatic cholangiocarcinoma, the mortality rates progressively increased from 0.15 per million in 1980 to 5.9 per million in 2003, when mortality for this cancer surpassed extra-hepatic cholangiocarcinoma. Mortality rates for extra-hepatic cholangiocarcinoma showed an increasing trend from 1980 to 1994 but, in contrast to intra-hepatic cholangiocarcinoma, a stable or slightly decreasing trend from 1995 to 2003 was observed.
CONCLUSIONS: In Italy, cholangiocarcinoma showed a progressive increase in incidence and mortality in the last two decades mainly in intra-hepatic cholangiocarcinoma. (c) 2009 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 20022823     DOI: 10.1016/j.dld.2009.10.009

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  36 in total

1.  Prostate apoptosis response-4 is expressed in normal cholangiocytes, is down-regulated in human cholangiocarcinoma, and promotes apoptosis of neoplastic cholangiocytes when induced pharmacologically.

Authors:  Antonio Franchitto; Alessia Torrice; Rossella Semeraro; Cristina Napoli; Gennaro Nuzzo; Felice Giuliante; Gianfranco Alpini; Guido Carpino; Pasquale Bartolomeo Berloco; Luciano Izzo; Antonio Bolognese; Paolo Onori; Anastasia Renzi; Alfredo Cantafora; Eugenio Gaudio; Domenico Alvaro
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

2.  Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity.

Authors:  Vincenzo Cardinale; Guido Carpino; Lola Reid; Eugenio Gaudio; Domenico Alvaro
Journal:  World J Gastrointest Oncol       Date:  2012-05-15

Review 3.  Systemic Therapy of Cholangiocarcinoma.

Authors:  Ruben R Plentz; Nisar P Malek
Journal:  Visc Med       Date:  2016-11-30

4.  The effect of adjuvant chemotherapy in patients with intrahepatic cholangiocarcinoma: a matched pair analysis.

Authors:  Nora Schweitzer; Tim Weber; Martha M Kirstein; Mareike Fischer; Anna-Maria Kratzel; Tanja Reineke-Plaaß; Frank Lehner; Michael P Manns; Arndt Vogel
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-17       Impact factor: 4.553

5.  Surgical outcomes and predicting factors of curative resection in patients with hilar cholangiocarcinoma: 10-year single-institution experience.

Authors:  Min Soo Cho; Sung Hoon Kim; Seung Woo Park; Jin Hong Lim; Gi Hong Choi; Joon Seong Park; Jae Bock Chung; Kyung Sik Kim
Journal:  J Gastrointest Surg       Date:  2012-07-14       Impact factor: 3.452

Review 6.  Cholangiocarcinoma: increasing burden of classifications.

Authors:  Vincenzo Cardinale; Maria Consiglia Bragazzi; Guido Carpino; Alessia Torrice; Alice Fraveto; Raffaele Gentile; Vincenzo Pasqualino; Fabio Melandro; Camilla Aliberti; Carlo Bastianelli; Roberto Brunelli; Pasquale Bartolomeo Berloco; Eugenio Gaudio; Domenico Alvaro
Journal:  Hepatobiliary Surg Nutr       Date:  2013-10       Impact factor: 7.293

Review 7.  [Diagnostics and treatment of cholangiocellular carcinoma].

Authors:  L Zender; N P Malek
Journal:  Internist (Berl)       Date:  2016-12       Impact factor: 0.743

8.  Intra-hepatic cholangiocarcinoma--frequency and demographic patterns: thirty-year data from the M.D. Anderson Cancer Center.

Authors:  Ashwani K Singal; Jean-Nicolas Vauthey; James J Grady; John R Stroehlein
Journal:  J Cancer Res Clin Oncol       Date:  2011-01-05       Impact factor: 4.553

Review 9.  Cholangiocarcinoma - evolving concepts and therapeutic strategies.

Authors:  Sumera Rizvi; Shahid A Khan; Christopher L Hallemeier; Robin K Kelley; Gregory J Gores
Journal:  Nat Rev Clin Oncol       Date:  2017-10-10       Impact factor: 66.675

10.  Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival.

Authors:  Caroline D M Witjes; Henrike E Karim-Kos; Otto Visser; Esther de Vries; Jan N M IJzermans; Robert A de Man; Jan Willem W Coebergh; Cornelis Verhoef
Journal:  HPB (Oxford)       Date:  2012-08-17       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.